53/ male burning feet since 2 months, not diabetic, hypertensive, b12 d3 in normal, suggest management
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Finding Sources
Here is a structured management approach for this 53-year-old male with burning feet for 2 months, non-diabetic, normotensive, with normal B12 and D3:
Burning Feet — Clinical Assessment & Management
What This Is Likely To Be
Burning feet in a middle-aged non-diabetic male with normal B12/D3 most commonly represents small fiber neuropathy (SFN) — a disorder of unmyelinated C-fibers and thinly myelinated Aδ-fibers. It presents as progressive burning pain in the feet, often with lancinating pain, numbness, and paresthesias. Reflexes and standard NCS/EMG are typically normal because large fibers are spared.
Step 1 — Identify the Cause (Investigations)
Even with normal B12 and D3, several other causes must be excluded:
| Category | Tests |
|---|---|
| Pre-diabetes / IGT | Fasting glucose, Oral Glucose Tolerance Test (OGTT), HbA1c — up to 56% of "idiopathic" sensory neuropathy patients have IGT on OGTT |
| Nutritional | Vitamin B1 (thiamine), B3 (niacin), B6 (pyridoxine), folate — B3 deficiency classically causes burning feet (small-fiber neuropathy pattern) |
| Thyroid | TSH — hypothyroidism causes neuropathy |
| Renal / hepatic | S. Creatinine, LFTs — metabolic neuropathies |
| Autoimmune | ANA, anti-Ro/La (Sjögren), ANCA, RF — connective tissue disease-associated neuropathy |
| Dysproteinemia | Serum protein electrophoresis (SPEP), immunofixation — monoclonal protein neuropathy |
| Amyloidosis | Consider if autonomic features present; abdominal fat pad biopsy |
| Heavy metals / toxins | Occupational history; heavy metal screen if suspected |
| Alcohol | Detailed alcohol history |
| HIV | HIV antibody (common painful sensory neuropathy) |
| Hereditary | Family history; transthyretin (TTR) mutation, SCN9A (NaV1.7) if idiopathic |
"Among 73 patients referred for distal idiopathic sensory neuropathy and screened with glucose tolerance testing, 56% had abnormal results — either IGT (36%) or frank diabetes" — Bradley and Daroff's Neurology in Clinical Practice
Step 2 — Confirm Small Fiber Neuropathy
Since standard NCS/EMG is normal in pure SFN:
- Quantitative Sensory Testing (QST) — elevated thermal thresholds
- QSART (Quantitative Sudomotor Axon Reflex Test) — impaired distal sweating; highly specific and sensitive
- Punch skin biopsy — reduced intraepidermal nerve fiber density (IENFD) — gold standard; safe and effective
- Diagnosis is best confirmed when ≥2 of: abnormal clinical findings + QST + QSART + skin biopsy
Step 3 — Management
A. Treat the Underlying Cause (if found)
- Pre-diabetes → lifestyle modification, metformin
- Nutritional deficiency → targeted supplementation (B-complex for B3/B1 deficiency)
- Autoimmune → disease-specific therapy (steroids, IVIG for vasculitic neuropathy)
- Hypothyroidism → levothyroxine
B. Symptomatic / Neuropathic Pain Treatment
First-line:
| Drug | Dose | Notes |
|---|---|---|
| Pregabalin | 75–150 mg BD | FDA-approved for neuropathic pain; faster titration than gabapentin |
| Gabapentin | 100–400 mg TID | Widely used; titrate slowly |
| Duloxetine | 30–60 mg OD | SNRI; first-line especially if comorbid depression/anxiety |
| Amitriptyline | 10–25 mg at night | TCA; use with caution in elderly/hypertensive |
Second-line:
- Topical capsaicin (0.025–0.075%) — applied to feet; desensitizes C-fibers
- Topical lidocaine patches
- Tramadol — weak opioid; useful for breakthrough pain
Opioids: Reserve for patients who have failed adequate trials of the above agents.
C. Non-pharmacological
- Avoid precipitating factors (heat, tight footwear, alcohol)
- Cooling footbaths for symptomatic relief
- Foot care and protection (risk of unnoticed trauma in severe SFN)
- Regular re-evaluation for an emerging underlying cause — especially repeat OGTT in 6–12 months
Summary
| Priority | Action |
|---|---|
| 1st | OGTT, HbA1c — exclude pre-diabetes |
| 2nd | B1, B3, B6, folate, TSH, LFTs, SPEP, ANA |
| 3rd | Skin punch biopsy / QSART to confirm SFN |
| Symptomatic | Pregabalin or gabapentin (first-line); duloxetine if affective features |
| Lifestyle | No alcohol, cool footwear, foot hygiene |
"Management of these common neuropathies centers on treating neuropathic pain, providing ankle braces in some cases, and patient education about the favorable long-term outcome. Periodic re-evaluation of patients in search of a possible underlying cause cannot be overemphasized." — Bradley and Daroff's Neurology in Clinical Practice
"The neurologic syndrome associated with B3 deficiency is presumed to be a small-fiber neuropathy with dysesthesias and paresthesias that result in 'burning feet.' Treatment is with B complex vitamins. Treatment with gabapentin may help relieve neuropathic symptoms." — Goldman-Cecil Medicine
This is a shared conversation. Sign in to Orris to start your own chat.